Controlled Nucleation for a Monoclonal Antibody Formulation—A Case Study

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2015
Volume 2015 eBook
Issue 2

This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.

 

This study evaluates the impact of controlled nucleation on the ability to optimize a lyophilization cycle for a monoclonal antibody formulation.

Download

Pharmaceutical Technology’s 2015 Bioprocessing and Sterile Manufacturing eBook


 

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content